NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 230 filers reported holding NOVOCURE LTD in Q3 2023. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $399 | -46.9% | 9,637 | -22.9% | 0.01% | -37.5% |
| Q1 2023 | $751 | -39.2% | 12,492 | -25.8% | 0.02% | -27.3% |
| Q4 2022 | $1,235 | -99.9% | 16,842 | 0.0% | 0.02% | -8.3% |
| Q3 2022 | $1,279,000 | +4.9% | 16,842 | 0.0% | 0.02% | +9.1% |
| Q2 2022 | $1,219,000 | -12.6% | 16,842 | 0.0% | 0.02% | +4.8% |
| Q1 2022 | $1,395,000 | +10.4% | 16,842 | 0.0% | 0.02% | +16.7% |
| Q4 2021 | $1,264,000 | -47.8% | 16,842 | -19.2% | 0.02% | -41.9% |
| Q3 2021 | $2,421,000 | -47.6% | 20,842 | 0.0% | 0.03% | -47.5% |
| Q2 2021 | $4,623,000 | +76.1% | 20,842 | +4.9% | 0.06% | +63.9% |
| Q1 2021 | $2,625,000 | -31.2% | 19,862 | -9.9% | 0.04% | -28.0% |
| Q4 2020 | $3,816,000 | – | 22,056 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |